Monday, September 15, 2025
HomeTagsHealthcare

Healthcare

IMI Releases Tamper Evident Caps with DoseID Certified RFID

IMI (International Medical Industries, Inc.) bolsters expertise in secure drug delivery products with the release of new Prep-Lock Tamper Evident Cap for ENFit® and...

JW Therapeutics Announces NMPA Acceptance of the Supplemental New Drug Application for Carteyva

JW Therapeutics (HKEx: 2126), an independent, innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, announced that the National Medical Products...

MOEA Supports ITRI to Launch iPMx Molecular Rapid Test System for COVID-19 in Japan with BizLink and Japan Biotechno Pharma

The iPMx Molecular Rapid Test System, developed by the Industrial Technology Research Institute (ITRI) with the support of Department of Industrial Technology (DoIT), Ministry...

Synaptogenix Moves Forward with Clinical Development Plans for Bryostatin-1 as a Treatment for Multiple Sclerosis

Synaptogenix, Inc., a clinical-stage biopharmaceutical company developing regenerative therapeutics for neurodegenerative disorders, announced plans to develop Bryostatin-1 for the treatment of multiple sclerosis ("MS"),...

Jupiter Neurosciences, Inc. Announces Completion of Phase I Safety Trial with Enhanced Resveratrol Product, JOTROL

Jupiter Neurosciences, Inc.,  announced the completion of its Phase I clinical trial with its proprietary JOTROL™, an enhanced formulation of resveratrol with increased bioavailability....
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics